The F-box protein Skp2 participates in c-Myc proteosomal degradation and acts as a cofactor for c-Myc-regulated transcription

Molecular Cell

Volumn 11, Issue 5, 2003, Pages 1189-1200

  Von Der Lehr, Natalie ^a   Johansson, Sara ^a   Wu, Siqin ^a   Bahram, Fuad ^a   Castell, Alina ^a   Cetinkaya, Cihan ^a   Hydbring, Per ^a   Weidung, Ingrid ^a   Nakayama, Keiko ^b   Nakayama, Keiichi I ^b   Söderberg, Ola ^c   Kerppola, Tom K ^d   Larsson, Lars Gunnar ^a  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b KYUSHU UNIVERSITY   (Japan)

^c UPPSALA UNIVERSITY   (Sweden)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEASOME; PROTEIN; PROTEIN SUBUNIT; S PHASE KINASE ASSOCIATED PROTEIN 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; FEMALE; GENE TARGETING; GENETIC TRANSCRIPTION; HOMEOBOX; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOCYTE; NONHUMAN; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ANIMALIA;

EID: 12444264823     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(03)00193-X     Document Type: Article

References (41)

1. Amati B., Frank S.R., Donjerkovic D., Taubert S. Function of the c-Myc oncoprotein in chromatin remodeling and transcription. Biochim. Biophys. Acta. 1471:2001;M135-M145.
2. Bahram F., Wu S., Oberg F., Luscher B., Larsson L.G. Posttranslational regulation of Myc function in response to phorbol ester/interferon-gamma-induced differentiation of v-Myc-transformed U-937 monoblasts. Blood. 93:1999;3900-3912.
3. Bahram F., von der Lehr N., Cetinkaya C., Larsson L.G. c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood. 95:2000;2104-2110.
4. Beier R., Burgin A., Kiermaier A., Fero M., Karsunky H., Saffrich R., Moroy T., Ansorge W., Roberts J., Eilers M. Induction of cyclin E-cdk2 kinase activity, E2F-dependent transcription and cell growth by Myc are genetically separable events. EMBO J. 19:2000;5813-5823.
5. Bouchard C., Dittrich O., Kiermaier A., Dohmann K., Menkel A., Eilers M., Luscher B. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network. Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter Genes Dev. 15:2001;2042-2047.
6. Brower C.S., Sato S., Tomomori-Sato C., Kamura T., Pause A., Stearman R., Klausner R.D., Malik S., Lane W.S., Sorokina I.et al. Mammalian mediator subunit mMED8 is an Elongin BC-interacting protein that can assemble with Cul2 and Rbx1 to reconstitute a ubiquitin ligase. Proc. Natl. Acad. Sci. USA. 99:2002;10353-10358.
7. Carrano A.C., Eytan E., Hershko A., Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1:1999;193-199.
8. Chi Y., Huddleston M.J., Zhang X., Young R.A., Annan R.S., Carr S.A., Deshaies R.J. Negative regulation of Gcn4 and Msn2 transcription factors by Srb10 cyclin-dependent kinase. Genes Dev. 15:2001;1078-1092.
9. Conaway R.C., Brower C.S., Conaway J.W. Emerging roles of ubiquitin in transcription regulation. Science. 296:2002;1254-1258.
10. DeSalle L.M., Pagano M. Regulation of the G1 to S transition by the ubiquitin pathway. FEBS Lett. 490:2001;179-189.
11. Desbarats L., Gaubatz S., Eilers M. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes Dev. 10:1996;447-460.
12. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
13. Ferdous A., Gonzalez F., Sun L., Kodadek T., Johnston S.A. The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Mol. Cell. 7:2001;981-991.
14. Flinn E.M., Busch C.M., Wright A.P. myc boxes, which are conserved in myc family proteins, are signals for protein degradation via the proteasome. Mol. Cell. Biol. 18:1998;5961-5969.
15. Frank S.R., Schroeder M., Fernandez P., Taubert S., Amati B. Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev. 15:2001;2069-2082.
16. Gonzalez F., Delahodde A., Kodadek T., Johnston S.A. Recruitment of a 19S proteasome subcomplex to an activated promoter. Science. 296:2002;548-550.
17. Grandori C., Cowley S.M., James L.P., Eisenman R.N. The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell Dev. Biol. 16:2000;653-699.
18. Gregory M.A., Hann S.R. c-Myc proteolysis by the ubiquitin-proteasome pathway. stabilization of c-Myc in Burkitt's lymphoma cells Mol. Cell. Biol. 20:2000;2423-2435.
19. Gstaiger M., Jordan R., Lim M., Catzavelos C., Mestan J., Slingerland J., Krek W. Skp2 is oncogenic and overexpressed in human cancers. Proc. Natl. Acad. Sci. USA. 98:2001;5043-5048.
20. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67:1998;425-479.
21. Hu C.D., Chinenov Y., Kerppola T.K. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell. 9:2002;789-798.
22. Kaiser P., Flick K., Wittenberg C., Reed S.I. Regulation of transcription by ubiquitination without proteolysis. Cdc34/SCF(Met30)-mediated inactivation of the transcription factor Met4 Cell. 102:2000;303-314.
23. Kato G.J., Barrett J., Villa-Garcia M., Dang C.V. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol. 10:1990;5914-5920.
24. Kuras L., Rouillon A., Lee T., Barbey R., Tyers M., Thomas D. Dual regulation of the met4 transcription factor by ubiquitin-dependent degradation and inhibition of promoter recruitment. Mol. Cell. 10:2002;69-80.
25. Latres E., Chiarle R., Schulman B.A., Pavletich N.P., Pellicer A., Inghirami G., Pagano M. Role of the F-box protein Skp2 in lymphomagenesis. Proc. Natl. Acad. Sci. USA. 98:2001;2515-2520.
26. Lisztwan J., Marti A., Sutterluty H., Gstaiger M., Wirbelauer C., Krek W. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2). evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway EMBO J. 17:1998;368-383.
27. Mateyak M.K., Obaya A.J., Adachi S., Sedivy J.M. Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ. 8:1997;1039-1048.
28. McMahon S.B., Van Buskirk H.A., Dugan K.A., Copeland T.D., Cole M.D. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell. 94:1998;363-374.
29. McMahon S.B., Wood M.A., Cole M.D. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc. Mol. Cell. Biol. 20:2000;556-562.
30. Molinari E., Gilman M., Natesan S. Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO J. 18:1999;6439-6447.
31. Muratani M., Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell Biol. 4:2003;192-201.
32. Nakayama K., Nagahama H., Minamishima Y.A., Matsumoto M., Nakamichi I., Kitagawa K., Shirane M., Tsunematsu R., Tsukiyama T., Ishida N.et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. EMBO J. 19:2000;2069-2081.
33. Ottosen S., Herrera F.J., Triezenberg S.J. Transcription. Proteasome parts at gene promoters. Science. 296:2002;479-481.
34. Salghetti S.E., Kim S.Y., Tansey W.P. Destruction of Myc by ubiquitin-mediated proteolysis. cancer-associated and transforming mutations stabilize Myc EMBO J. 18:1999;717-726.
35. Salghetti S.E., Muratani M., Wijnen H., Futcher B., Tansey W.P. Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. Proc. Natl. Acad. Sci. USA. 97:2000;3118-3123.
36. Salghetti S.E., Caudy A.A., Chenoweth J.G., Tansey W.P. Regulation of transcriptional activation domain function by ubiquitin. Science. 293:2001;1651-1653.
37. Sears R., Leone G., DeGregori J., Nevins J.R. Ras enhances Myc protein stability. Mol. Cell. 3:1999;169-179.
38. Sutterluty H., Chatelain E., Marti A., Wirbelauer C., Senften M., Muller U., Krek W. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1:1999;207-214.
39. Treier M., Staszewski L.M., Bohmann D. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell. 78:1994;787-798.
40. Weissman A.M. Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2:2001;169-178.
41. Zeller K.I., Haggerty T.J., Barrett J.F., Guo Q., Wonsey D.R., Dang C.V. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J. Biol. Chem. 276:2001;48285-48291.